Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dimethylformamide (DMF) hepatotoxicity.

V Scailteur, R R Lauwerys

    Toxicology
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Dimethylformamide (DMF) exposure primarily targets the liver, causing symptoms like ethanol intolerance and elevated liver enzymes in humans. The exact cellular damage mechanism leading to DMF hepatotoxicity remains unidentified.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cellular metabolism of arsenic studied in mammalian cellsin vitro.

    Environmental geochemistry and health·2013
    Same author

    Lung retention and bioavailability of arsenic after single intratracheal administration of sodium arsenite, sodium arsenate, fly ash and copper smelter dust in the hamster.

    Environmental geochemistry and health·2013
    Same author

    Epidemiological survey of workers exposed to inorganic germanium compounds.

    Occupational and environmental medicine·2000
    Same author

    Human volunteer studies; a consumer products company view.

    Human & experimental toxicology·1999
    Same author

    The assessment of biomarkers to detect nephrotoxicity using an integrated database.

    Environmental research·1997
    Same author

    Hematopoietic and lymphatic malignancies in vehicle mechanics.

    Critical reviews in toxicology·1997
    Same journal

    Retraction notice to "Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro" [Toxicology 283 (2011) 129-139].

    Toxicology·2026
    Same journal

    Crystalline silica particles exposure modulated miRNA expression profiles in human macrophage-like THP-1 cells.

    Toxicology·2026
    Same journal

    Sex-specific cellular and molecular mechanisms of PFAS-induced reproductive toxicity.

    Toxicology·2026
    Same journal

    Neurotoxicity and Mechanisms of Deltamethrin and Its Metabolite 3-PBA in HT22 Cells.

    Toxicology·2026
    Same journal

    Polystyrene nanoplastics impair epithelial barrier establishment and modulate extracellular vesicle release in human bronchial cells cultured at the air-liquid interface.

    Toxicology·2026
    Same journal

    Effects of HFPO-DA (GenX) exposure on placental glycolysis and metabolic microenvironment in pregnant rats.

    Toxicology·2026
    See all related articles

    Area of Science:

    • Toxicology
    • Hepatology
    • Occupational Health

    Background:

    • Dimethylformamide (DMF) is recognized as a hepatotoxic agent, with the liver identified as the primary target organ in both humans and animal models.
    • Human exposure to DMF can lead to ethanol intolerance, gastrointestinal distress (nausea, vomiting, abdominal pain), and elevated plasma liver enzymes.

    Purpose of the Study:

    • To summarize the known effects of dimethylformamide (DMF) exposure on the liver.
    • To highlight the current understanding of DMF's metabolic pathways and the remaining gaps in knowledge regarding its cellular mechanisms of hepatotoxicity.

    Main Methods:

    • Review of scattered case reports on accidental exposure.
    • Analysis of epidemiological studies investigating DMF exposure.
    • Examination of animal studies confirming DMF's hepatotoxicity.

    Related Experiment Videos

  • Synthesis of recent findings on DMF metabolic pathways.

    • Main Results:

    • The liver is consistently identified as the main target organ for both acute and chronic dimethylformamide (DMF) exposure.
    • Early human health effects include ethanol intolerance, progressing to other symptoms and liver enzyme release at higher exposure levels.
    • While the metabolic pathway of DMF is understood, the specific cellular lesion causing liver damage is yet to be determined.

    Conclusions:

    • Dimethylformamide (DMF) poses a significant risk to liver health, necessitating awareness and preventative measures in occupational settings.
    • Further research is crucial to elucidate the primary cellular mechanisms underlying DMF-induced hepatotoxicity.